Literature DB >> 7416626

Possible thiabendazole-induced theophylline toxicity.

A M Sugar, P J Kearns, A A Haulk, J L Rushing.   

Abstract

Strongyloidiasis in immunosuppressed patients often requires prolonged administration of the antihelminthic, thiabendazole. The case described herein represents the first report of theophylline toxicity induced by concurrent administration of thiabendazole. Preliminary studies suggest that interference with theophylline clearance by thiabendazole may be the mechanism involved in this drug interaction.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7416626     DOI: 10.1164/arrd.1980.122.3.501

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  4 in total

Review 1.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

2.  Seizures from theophylline use.

Authors:  R G Dellen
Journal:  West J Med       Date:  1983-03

3.  Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis.

Authors:  R M Genta; R W Douce; P D Walzer
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

Review 4.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.